Stock Events

Stock Events

C4 Therapeutics (CCCC) Q4 2023 Earnings

22FebConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.75

-0.68

-0.62

-0.55

Details

Expected EPS

-0.686919

Actual EPS

-0.68

Surprise EPS

0.01

Surprise Percent

+1.01%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.68 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.